SolasCure Enrolls First Patient in Phase II Aurase Wound Trial
Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd, a biotechnology...